Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA melamine alert

This article was originally published in The Tan Sheet

Executive Summary

On Nov. 12, FDA issued an import alert ordering all milk products, milk-derived ingredients and finished food products with milk from China be detained without physical examination due to the possible presence of melamine or melamine analogs. To secure release of shipments, importers must provide results of a third-party lab analysis verifying the absence of melamine and cyanuric acid, or documentation showing the product contains no milk or milk-derived ingredients. FDA also issued an interim safety and risk assessment of melamine in human food, saying in a Nov. 13 Federal Register notice it cannot establish a safe level of melamine and its analogues in infant formula. In foods for older children and adults, levels of melamine and melamine-related compounds below 2.4 ppm do not raise public health concerns, FDA says. The agency adds it does not approve melamine use in direct addition to food or as a fertilizer in the U.S. Comments on the paper, which was drafted after melamine-tainted infant formula caused 13,000 hospitalizations and three deaths. Comments are due Jan. 12 (1"The Tan Sheet" Sept. 15, 2008, In Brief)

Related Content

Topics

UsernamePublicRestriction

Register

PS102307

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel